Dianthus Therapeutics | Des Atouts



Assets Changement Date
Adcock Ingram Holdings ZAR 8.74B 388.13M 2024-12
Alaunos Therapeutics USD 2.76M 795K 2024-12
Avita Medical AUD 79.71M 8.12M 2024-12
Celltrion KRW 20.96T 20.29T 2025-03
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Dianthus Therapeutics USD 374.01M 19.76M 2024-12
Divis Laboratories Ltd 169.32B 13.46B 2025-03
IQVIA Holdings USD 27.32B 423M 2025-03
Kangmei Pharma CNY 14.19B 63.4M 2024-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 832.02M 25.3M 2024-12
Malin Corporation EUR 128.4M 11.8M 2024-06
Medical Developments International AUD 59.16M 31.9M 2024-06
Moderna USD 12.7B 1.44B 2025-03
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Organon & Co USD 13.16B 55M 2025-03
Pharma Mar EUR 333.5M 16.15M 2025-03
Qiagen NV USD 5.69B 580.57M 2024-12
Revvity USD 12.36B 31.75M 2025-03
Sartorius EUR 10.11B 9.3M 2025-03
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Tectonic Therapeutic USD 152.9M 15.81M 2024-12
Tilray USD 4.19B 70.11M 2024-11
Viatris USD 38.47B 3.03B 2025-03
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12
Zz Pientze Pharmaceu 18.48B 944.93M 2025-03



Dianthus Therapeutics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.